002981.SZ
Risuntek Inc. [002981.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002981.SZ Stock Summary
Top 10 Correlated Stocks
002981.SZ
In the News
002981.SZ Financial details
Company Rating
Buy
Market Cap
2.88B
Income
94.33M
Revenue
1.41B
Book val./share
8.94
Cash/share
1.84
Dividend
0.15
Dividend %
0.39%
Employees
2.33K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
39.24
Forward P/E
-
PEG
-1.2
P/S
2.64
P/B
4.31
P/C
14.64
P/FCF
272.53
Quick Ratio
0.97
Current Ratio
1.4
Debt / Equity
0.18
LT Debt / Equity
0.06
-
-
EPS (TTM)
0.98
EPS next Y
-
EPS next Q
-
EPS this Y
-241.86%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.63%
Revenue last 5Y
18.42%
Revenue Q/Q
31.71%
EPS Q/Q
65.52%
-
-
-
-
SMA20
-6.45%
SMA50
-3.33%
SMA100
-25.64%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
12%
ROC
0.11%
Gross Margin
24%
Oper. Margin
8%
Profit Margin
7%
Payout
21%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
21.02-46.53
52W High
-41.46%
52W Low
+28.24%
RSI
35
Rel Volume
0.78
Avg Volume
2.81M
Volume
2.19M
Perf Week
-12.42%
Perf Month
-12.65%
Perf Quarter
0.86%
Perf Half Y
-0.59%
-
-
-
-
Beta
0.111
-
-
Volatility
2.2%, 1.85%
Prev Close
7.81%
Price
26.93
Change
-1.93%
002981.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 8.27 | 8.62 | 9.42 | 13.64 | 14.43 | |
| Net income per share | 1.07 | 0.87 | 0.47 | -0.43 | 0.61 | |
| Operating cash flow per share | 1.17 | 0.56 | 0.42 | 1.29 | 0.33 | |
| Free cash flow per share | 0.93 | -0.39 | -1.6 | -0.87 | -0.02 | |
| Cash per share | 1.37 | 0.69 | 3.66 | 2.28 | 2.25 | |
| Book value per share | 5.21 | 4.62 | 8.7 | 8.22 | 8.3 | |
| Tangible book value per share | 5.02 | 4.12 | 7.99 | 7.51 | 6.83 | |
| Share holders equity per share | 5.21 | 4.62 | 8.7 | 8.22 | 8.3 | |
| Interest debt per share | 0.01 | 0.2 | 0.96 | 0.86 | 2.37 | |
| Market cap | 1.79B | 2.39B | 2.68B | 2.11B | 2.83B | |
| Enterprise value | 1.69B | 2.35B | 2.52B | 2.02B | 2.79B | |
| P/E ratio | 23.31 | 28.8 | 58.92 | -50.61 | 48.77 | |
| Price to sales ratio | 3.01 | 2.89 | 2.96 | 1.61 | 2.05 | |
| POCF ratio | 21.25 | 44.41 | 65.92 | 16.96 | 88.49 | |
| PFCF ratio | 26.96 | -64.73 | -17.43 | -25.12 | -1.4K | |
| P/B Ratio | 4.78 | 5.4 | 3.21 | 2.67 | 3.56 | |
| PTB ratio | 4.78 | 5.4 | 3.21 | 2.67 | 3.56 | |
| EV to sales | 2.85 | 2.84 | 2.78 | 1.54 | 2.01 | |
| Enterprise value over EBITDA | 16.54 | 19.76 | 34.53 | 147.88 | 16.07 | |
| EV to operating cash flow | 20.08 | 43.54 | 61.97 | 16.24 | 87.02 | |
| EV to free cash flow | 25.47 | -63.46 | -16.39 | -24.05 | -1.38K | |
| Earnings yield | 0.04 | 0.03 | 0.02 | -0.02 | 0.02 | |
| Free cash flow yield | 0.04 | -0.02 | -0.06 | -0.04 | 0 | |
| Debt to equity | 0 | 0.04 | 0.11 | 0.1 | 0.27 | |
| Debt to assets | 0 | 0.03 | 0.07 | 0.06 | 0.13 | |
| Net debt to EBITDA | -0.96 | -0.4 | -2.2 | -6.58 | -0.27 | |
| Current ratio | 2.98 | 1.8 | 2.17 | 1.31 | 1.41 | |
| Interest coverage | 216.02 | 1.19K | 31.77 | -4.51 | 10.33 | |
| Income quality | 1.1 | 0.65 | 0.89 | -2.98 | 0.52 | |
| Dividend Yield | 0.01 | 0.01 | 0 | 0 | 0 | |
| Payout ratio | 0.24 | 0.17 | 0.24 | -0.24 | 0.13 | |
| Sales general and administrative to revenue | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Research and developement to revenue | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | |
| Intangibles to total assets | 0.03 | 0.06 | 0.06 | 0.05 | 0.12 | |
| Capex to operating cash flow | -0.21 | -1.69 | -4.78 | -1.67 | -1.06 | |
| Capex to revenue | -0.03 | -0.11 | -0.21 | -0.16 | -0.02 | |
| Capex to depreciation | -1.58 | -6.66 | -10.41 | -6.11 | -0.59 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0 | |
| Graham number | 11.2 | 9.49 | 9.63 | 8.95 | 10.63 | |
| ROIC | 0.2 | 0.18 | 0.05 | -0.02 | 0.11 | |
| Return on tangible assets | 0.16 | 0.12 | 0.04 | -0.03 | 0.04 | |
| Graham Net | 2.12 | 0.85 | 2.89 | -0.37 | -1.78 | |
| Working capital | 261.11M | 250.28M | 466.86M | 181.21M | 250.65M | |
| Tangible asset value | 360.67M | 395.07M | 766.82M | 720.85M | 656.03M | |
| Net current asset value | 261.11M | 249.88M | 464.12M | 176.74M | 99.07M | |
| Invested capital | 0 | 0.04 | 0.11 | 0.1 | 0.27 | |
| Average receivables | 177.5M | 251.57M | 316.33M | 303.78M | 315.28M | |
| Average payables | 109.51M | 188.97M | 276.92M | 388.07M | 430.91M | |
| Average inventory | 109.87M | 135.36M | 179.47M | 213.04M | 242.2M | |
| Days sales outstanding | 103.77 | 147.3 | 120.49 | 86.09 | 84.74 | |
| Days payables outstanding | 90.91 | 151.27 | 138.65 | 148.55 | 119.02 | |
| Days of inventory on hand | 97.1 | 86.37 | 99.84 | 66.68 | 84.62 | |
| Receivables turnover | 3.52 | 2.48 | 3.03 | 4.24 | 4.31 | |
| Payables turnover | 4.01 | 2.41 | 2.63 | 2.46 | 3.07 | |
| Inventory turnover | 3.76 | 4.23 | 3.66 | 5.47 | 4.31 | |
| ROE | 0.21 | 0.19 | 0.05 | -0.05 | 0.07 | |
| Capex per share | -0.25 | -0.95 | -2.02 | -2.17 | -0.35 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.94 | 3.95 | 2.3 | 3.63 | 4.78 | |
| Net income per share | 0.26 | 0.18 | 0.03 | 0.29 | 0.48 | |
| Operating cash flow per share | 0.26 | 0.18 | 0.03 | 0.32 | 0.51 | |
| Free cash flow per share | 0.2 | 0.24 | -0.16 | -0.18 | 0.24 | |
| Cash per share | 2.02 | 2.25 | 1.75 | 1.46 | 1.84 | |
| Book value per share | 8.7 | 8.3 | 8.31 | 8.51 | 8.94 | |
| Tangible book value per share | 7.21 | 6.83 | 6.87 | 7.07 | 7.52 | |
| Share holders equity per share | 8.7 | 8.3 | 8.31 | 8.51 | 8.94 | |
| Interest debt per share | 2.97 | 2.32 | 1.97 | 1.81 | 1.56 | |
| Market cap | 1.98B | 2.83B | 2.74B | 2.31B | 2.62B | |
| Enterprise value | 2.09B | 2.79B | 2.72B | 2.3B | 2.59B | |
| P/E ratio | 19.55 | 40.11 | 283.38 | 20.56 | 14.18 | |
| Price to sales ratio | 5.24 | 7.47 | 12.44 | 6.64 | 5.7 | |
| POCF ratio | 78.2 | 160.43 | 1.13K | 75.82 | 53.63 | |
| PFCF ratio | 104.24 | 121.13 | -173.78 | -132.95 | 111.68 | |
| P/B Ratio | 2.37 | 3.56 | 3.44 | 2.83 | 3.05 | |
| PTB ratio | 2.37 | 3.56 | 3.44 | 2.83 | 3.05 | |
| EV to sales | 5.52 | 7.35 | 12.32 | 6.61 | 5.64 | |
| Enterprise value over EBITDA | 73.74 | 48.09 | 944.03 | 53.08 | 47.19 | |
| EV to operating cash flow | 82.45 | 157.76 | 1.12K | 75.45 | 53.09 | |
| EV to free cash flow | 109.9 | 119.12 | -172.06 | -132.31 | 110.57 | |
| Earnings yield | 0.01 | 0.01 | 0 | 0.01 | 0.02 | |
| Free cash flow yield | 0.01 | 0.01 | -0.01 | -0.01 | 0.01 | |
| Debt to equity | 0.3 | 0.27 | 0.23 | 0.21 | 0.18 | |
| Debt to assets | 0.15 | 0.13 | 0.12 | 0.11 | 0.1 | |
| Net debt to EBITDA | 3.8 | -0.81 | -9.46 | -0.26 | -0.48 | |
| Current ratio | 1.42 | 1.41 | 1.33 | 1.38 | 1.4 | |
| Interest coverage | -0.24 | 3.59 | 1 | 17.99 | -13.35 | |
| Income quality | 1 | 1 | 1 | 1.08 | 1.06 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
| Payout ratio | 0.14 | 0.03 | 0.78 | 0.56 | 0.04 | |
| Sales general and administrative to revenue | 0.13 | -0.1 | 0.11 | -0.01 | 0.12 | |
| Research and developement to revenue | 0.04 | 0.03 | 0.05 | 0.04 | 0.03 | |
| Intangibles to total assets | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | |
| Capex to operating cash flow | -0.25 | 0.32 | -7.52 | -1.57 | -0.52 | |
| Capex to revenue | -0.02 | 0.02 | -0.08 | -0.14 | -0.06 | |
| Capex to depreciation | -0.35 | 0.32 | -1.2 | -3.15 | 0.87 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 7.19 | 5.86 | 2.17 | 7.49 | 9.83 | |
| ROIC | -0.01 | 0.02 | 0 | 0.03 | 0.05 | |
| Return on tangible assets | 0.02 | 0.01 | 0 | 0.02 | 0.03 | |
| Graham Net | -1.26 | -1.78 | -2.02 | -1.73 | -1.17 | |
| Working capital | 261.39M | 250.65M | 198.74M | 211.24M | 232.73M | |
| Tangible asset value | 692.5M | 656.03M | 659.59M | 678.85M | 721.68M | |
| Net current asset value | 128.85M | 99.07M | 78.24M | 93.18M | 117.41M | |
| Invested capital | 0.3 | 0.27 | 0.23 | 0.21 | 0.18 | |
| Average receivables | 400.36M | 362.36M | 304.52M | 301.73M | 355.33M | |
| Average payables | 449.56M | 380.27M | 385.35M | 385.54M | 397.78M | |
| Average inventory | 314.12M | 270.7M | 275.89M | 271.72M | 244.98M | |
| Days sales outstanding | 95.99 | 76.31 | 117.27 | 81.63 | 77.37 | |
| Days payables outstanding | 109.12 | 121.74 | 207 | 123.21 | 109.69 | |
| Days of inventory on hand | 77.76 | 86.56 | 149.16 | 84.76 | 60.6 | |
| Receivables turnover | 0.94 | 1.18 | 0.77 | 1.1 | 1.16 | |
| Payables turnover | 0.82 | 0.74 | 0.43 | 0.73 | 0.82 | |
| Inventory turnover | 1.16 | 1.04 | 0.6 | 1.06 | 1.49 | |
| ROE | 0.03 | 0.02 | 0 | 0.03 | 0.05 | |
| Capex per share | -0.07 | 0.06 | -0.19 | -0.5 | -0.26 |
002981.SZ Frequently Asked Questions
What is Risuntek Inc. stock symbol ?
Risuntek Inc. is a CN stock and trading under the symbol 002981.SZ
What is Risuntek Inc. stock quote today ?
Risuntek Inc. stock price is $26.93 today.
Is Risuntek Inc. stock public?
Yes, Risuntek Inc. is a publicly traded company.
Company Profile
- Volume Average 2.81M
- Market Capitalization 2.88B
- Employee 2.33K
- CEO Mr. Qingkai Shen
- Headquarters Dongguan,CN
- IPO Date 2020-04-17
-
Website
https://www.risuntek.com 
Risuntek Inc. researches, develops, manufactures, and sells electroacoustic products and components. The company was founded in 2005 and is based in Guangdong, China.
